Insights from the EADV 2022 ADVENT symposium, exploring the role of type 2 inflammation in skin barrier and neuroimmune dysfunction in atopic dermatitis.
Skin barrier dysfunction and neuroimmune dysfunction are hallmarks of atopic dermatitis, that are driven in part by type 2 inflammation. In this ADVENT-sponsored symposium at the EADV 2022 Congress in Milan, experts Donald Leung, MD, PhD (National Jewish Health in Denver, USA), Anna De Benedetto, MD (University of Rochester, USA), Gil Yosipovitch (Miami Itch Center, USA), and Michael J. Cork MD, PhD (University of Sheffield, UK), delve into the triad of interacting mechanisms involved in driving atopic dermatitis pathophysiology: type 2 inflammation, barrier dysfunction, and neuroimmune axis dysregulation. In this session, experts also explore innovative methods to evaluate and restore skin barrier function.